Early Phase 1 Breast Clinical Trials
25 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–20 of 25 trials
Recruiting
Early Phase 1
Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute16 enrolled1 locationNCT06435351
Recruiting
Early Phase 1
Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System
Breast Cancer
University of Utah34 enrolled1 locationNCT05291507
Recruiting
Early Phase 1
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+20 more
Ohio State University Comprehensive Cancer Center50 enrolled1 locationNCT05417308
Recruiting
Early Phase 1
Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms
Breast CancerAromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)Joint Pain
Philip Chang30 enrolled2 locationsNCT06123286
Recruiting
Early Phase 1
FES BPET-DBT in Newly Diagnosed Breast Cancer
Breast Cancer
Abramson Cancer Center at Penn Medicine20 enrolled1 locationNCT05659797
Recruiting
Early Phase 1
Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC
Breast Cancer
Baylor Research Institute20 enrolled1 locationNCT04265872
Recruiting
Early Phase 1
B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer.
Breast CancerPancreatic CancerPulmonary Cancer+4 more
Poitiers University Hospital220 enrolled1 locationNCT07236177
Recruiting
Early Phase 1
Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness
Breast Cancer
University of Alabama at Birmingham10 enrolled1 locationNCT03321045
Recruiting
Early Phase 1
Neuromodulation of Cardiovascular Risks Associated With Cardiotoxic Chemotherapy
Breast CancerLymphoma
University of Oklahoma104 enrolled2 locationsNCT05921253
Recruiting
Early Phase 1
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
Breast CancerHER2-positive Breast CancerLocally Advanced Breast Cancer+1 more
Alison Stopeck30 enrolled1 locationNCT06220214
Recruiting
Early Phase 1
A Prospective, Open-label, Single-arm, Exploratory Clinical Trial to Evaluate the Safety and Tolerability of 225Ac-TR2205 Injection in Patients With Triple-negative Breast Cancer.
Advanced Metastatic Triple-negative Breast Cancer (mTNBC)
Xiaorong Sun15 enrolled1 locationNCT07340424
Recruiting
Early Phase 1
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
Breast Carcinoma
Mayo Clinic55 enrolled1 locationNCT05704283
Recruiting
Early Phase 1
PET-imaging of Two Vartumabs in Patients With Solid Tumors
Breast CancerBladder CarcinomaEsophageal Carcinoma+11 more
Var2 Pharmaceuticals32 enrolled1 locationNCT06645808
Recruiting
Early Phase 1
MUSE-S Headband System for Improving Anxiety and Insomnia Among Breast Cancer Survivors
Breast Carcinoma
Mayo Clinic40 enrolled1 locationNCT06274034
Recruiting
Early Phase 1
A Study of GC101 TIL in Advanced Breast Cancer (10hospital)
Breast CancerAdvanced Breast CancerTreatment Side Effects+1 more
Shanghai Juncell Therapeutics50 enrolled1 locationNCT05142475
Recruiting
Early Phase 1
Neratinib in Combination With Ruxolitinib in Patients With mTNBC
Breast CancerMetastatic Triple-Negative Breast Carcinoma
Baylor Research Institute20 enrolled1 locationNCT06008275
Recruiting
Early Phase 1
Comparison of CE-DBT and MRI in Patients With Known Breast Lesions
Breast Cancer
UNC Lineberger Comprehensive Cancer Center20 enrolled1 locationNCT05754749
Recruiting
Early Phase 1
Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer
Breast Cancer
Peking Union Medical College Hospital50 enrolled1 locationNCT06411678
Recruiting
Early Phase 1
Letrozole With and Without Simvastatin for the Treatment of Stage I-III Hormone Receptor Positive, HER2 Negative Breast Cancer
HER2-Negative Breast CarcinomaAnatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+3 more
Emory University40 enrolled4 locationsNCT05464810
Recruiting
Early Phase 1
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
TNBC - Triple-Negative Breast CancerLocally Advanced Triple Negative Breast Cancer
Rima Patel15 enrolled1 locationNCT06637306